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Panic-Prone State Induced in Rats with GABA Dysfunction
in the Dorsomedial Hypothalamus Is Mediated by
NMDA Receptors
Philip L. Johnson and Anantha Shekhar
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202
Rats with chronic inhibition of GABA synthesis and consequently enhanced glutamatergic excitation in the dorsomedial hypothalamus
(DMH) develop panic-like responses, defined as tachycardia, tachypnea, hypertension, and increased anxiety as measured by a social
interaction (SI) test, after intravenous sodium lactate infusions, a phenomenon similar to patients with panic disorder. Therefore, the
present studies tested the role of the postsynaptic NMDA and AMPA type glutamatergic receptors in the lactate-induced panic-like
responses in these rats. Ratswere fitwith femoral arterial andvenous catheters andAlzet pumps [filledwith theGABAsynthesis inhibitor
L-allylglycine (L-AG; 3.5 nmol/0.5l per hour) or its inactive isomer D-AG] into theDMH.After 4–5dof recovery only those ratswith L-AG
pumps exhibited panic-like responses to lactate infusions. Using double immunocytochemistry, we found that rats exhibiting panic-like
responses (e.g., L-AG plus lactate) had increased c-Fos immunoreactivity in DMH neurons expressing the NMDA receptor 1 (NR1)
subunit, but not those expressing the glutamate receptor 2 and 3 subunits of the AMPA receptors. To confirm this pharmacologically, we
tested another group of rats implanted with L-AG pumps with intravenous lactate infusions preceded by injections of either NMDA
[aminophosphonopentanoic acid (AP-5) or ()-5-methyl-10,11-dihydro-5H-dibenzo [a,d]cyclohepten-5,10-imine maleate (MK-801)]
or non-NMDA [CNQX or 4-(8-methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodazepin-5-yl)-benzenamine dihydrochloride (GYKI52466)] an-
tagonists into the DMH. Injections of NMDA, but not non-NMDA, antagonists into the DMH resulted in dose-dependent blockade of the
tachycardia, tachypnea, hypertension, and SI responses after lactate infusions. These results suggest that NMDA, and not non-NMDA,
type glutamate receptors regulate lactate-induced panic-like responses in rats with GABA dysfunction in the DMH.
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hypotension; lactate; panic
Introduction
Panic disorder is a severe anxiety disorder characterized by recur-
rent panic attacks, affects1–2% of the population, and results
in significant morbidity and mortality (Weissman and Merikan-
gas, 1986; Kessler et al., 1994; Hirschfeld, 1996; Katon et al.,
2002). Subjects with panic disorder are hypothesized to have dis-
rupted regulation of autonomic and respiratory pathways (Klein,
1993). Consistent with this, subjects with panic disorder are sus-
ceptible to panic-like responses after chemical stimuli such as
sodium lactate (Liebowitz et al., 1984), CO2 inhalation (Gorman
et al., 1994), or yohimbine (Charney et al., 1984) challenges.
A number of limbic and autonomic regulatory centers have
been implicated in the pathophysiology of panic disorder and
lactate sensitivity (Gorman et al., 2000; Shekhar et al., 2003). The
dorsomedial hypothalamus (DMH) is one such site that coordi-
nates neuroendocrine, autonomic, andbehavioral responses for a
variety of homeostatic mechanisms (Bernardis and Bellinger,
1998; DiMicco et al., 2002; Chou et al., 2003). Blocking GABAA
neurotransmission in the DMH of rats elicits panic-like re-
sponses such as increases in heart rate (HR), respiratory rate
(RR), mean arterial blood pressure (MAP), and experimental
anxiety (DiMicco et al., 1986; DiMicco and Abshire, 1987; Shek-
har, 1993). Thus the DMH could be an important anatomical
substrate in the “panic circuit” (Shekhar, 1994; Shekhar and Kat-
ner, 1995). In support of this hypothesis, rats with chronic infu-
sions of the GABA synthesis inhibitor L-allylglycine (L-AG) into
the DMH through minipumps show physiological responses to
lactate infusions similar to those in panic disorder patients (Shek-
har et al., 1996; Shekhar and Keim, 1997).
There appears to be a balance between tonic GABAergic inhi-
bition and glutamate-mediated excitation within the DMH that
regulates lactate responses (Shekhar and Keim, 2000). Under
basal conditions the activity of DMH neurons is regulated by a
tonic GABAergic inhibition of excitatory glutamatergic (both
non-NMDA and NMDA) drive (Soltis and DiMicco, 1991).
However, when the GABAergic inhibitory tone is reduced with
L-AG infusions, the glutamate-mediated excitation appears to
become prominent, leading to chronic activation and a panic-
prone state, because reduction of glutamate release by a presyn-
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aptic agonist of the metabotropic glutamate autoreceptors re-
verses this effect (Shekhar and Keim, 2000).
The purpose of this study was to investigate the postsynaptic
receptor mechanisms of enhanced glutamatergic excitation after
chronic disruption of GABA synthesis in the DMH that results in
lactate-induced panic-like responses. So that we could determine
what role NMDA and AMPA receptors in the DMH play in this
panic model, rats received unilateral infusions of L-AG or its
inactive isomer D-AG (3.5 nmol/0.5 l per hour) into the DMH
for 4–5 d; they received intravenous infusions of 0.5 M sodium
lactate (Lac) or saline (Sal) and were fixed with 4% paraformal-
dehyde. Double immunocytochemistry was used to assess cellu-
lar responses (as measured by the presence of c-Fos, the protein
product of the immediate early gene c-fos) in DMH neurons ex-
pressing either NMDA or AMPA receptor subunits. The NMDA
receptor (NR) is made up of the NR1 and NR2 subunits, whereas
the AMPA receptor is made up of glutamate receptor 1–4
(GluR1–4) subunits. Antibodies that recognize the NR1 subunit
of the NMDA receptor and the GluR2 and 3 subunits of the
AMPA receptor were used. We selected these antibodies because
the NR1 protein (Petralia et al., 1994) and mRNA (Eyigor et al.,
2001) and the GluR2 and 3 proteins (Petralia et al., 1996) and
mRNA (Eyigor et al., 2001) expressions are most ubiquitous in
the DMH and are equal to or greater than NR2 and GluR1 and 4
subunits. In another group of rats, which received L-AG infusions
into theDMHandwere responsive to intravenous sodium lactate
infusions, the lactate responses were retested after acute injection
of NMDA and non-NMDA antagonists into the DMH.
Materials andMethods
General procedures
Animals and housing conditions. All experiments were conducted on
adultmale SpragueDawley rats (300–350 g), whichwere purchased from
Harlan Laboratories (Indianapolis, IN) and were housed individually in
plastic cages under standard environmental conditions (72 F°; 12 h light/
dark cycle; lights on at 7:00 A.M.) for 7–10 d before the surgical manip-
ulations. Food and water were provided ad libitum. Animal care proce-
dures were conducted in accordance with the National Institutes of
Health (NIH)Guidelines for theCare andUse of LaboratoryAnimals (NIH
publication 80-23, revised in 1996) and the guidelines of the Indiana
University–Purdue University Indianapolis Institutional Animal Care
and Use Committee.
Surgical procedures and osmoticminipump infusions.Before surgery the
rats were anesthetized with isoflurane after removing them from their
home cages andplacing them in a closedPlexiglas box thatwas connected
to an isoflurane system (MGXResearchMachine; Vetamic, Rossville, IN)
and then with a nose cone connected to the same system during the
surgery. All rats were fit with femoral arterial catheters for measurement
of HR and MAP and with venous catheters for intravenous infusions, as
previously described (Shekhar, 1993). After 3 d of recovery the animals
were tested for baseline physiological and behavioral responses to lactate
(see below). Each rat thenwas anesthetized as previously indicated before
the implantation of a 28 gauge cannula attached to a T-shaped Alzet
osmoticminipump (catalog #3260PG, 26 gauge; Durect, Cupertino, CA)
as described previously (Shekhar et al., 1996). Briefly, cannulas were
directed at cardioexcitatory regions of the DMH (Samuels et al., 2004)
based on the following coordinates frombregma: 1.2mmposterior,0.5
mm lateral, 8.5 mm ventral, and adjusted for approaching at a 10°
angle toward the midline, with the stereotaxic incisor bar elevated 5 mm
above the interaural line. A T-shaped pump cannula with a side arm
attached to a small Tygon tube was used for pump implantations. Once
the cannula was placed at the coordinates targeting the DMH, 50 pmol/
100 nl of the GABAA receptor antagonist bicuculline methiodide (BMI)
was injected through the vertical arm of the cannula via an injection
cannula to ascertain that the tip of the pump cannula was placed in a
cardioexcitatory region (i.e., where BMI elicits 50 beats/min in HR).
Once the reactive site was found, the vertical arm of the cannula was
closed by using a stylette, and the side tubing was connected to the metal
connector in the minipump that was filled previously with the desired
infusion fluid of either the inactive D- or the active L- isomer of allylgly-
cine (D- or L-AG, respectively), an inhibitor of GABA synthesis, in exper-
iment 1 or L-AG only in experiment 2. Then the pumpwas sutured under
the skin in the nape of the neck, and the connector and cannula were
cemented to the skull as described previously (Shekhar et al., 1996). The
concentration of the AG solutionswas such that 3.5 nmol/0.5l per hour
of the drug was infused into the DMH region over a 5 d period before
intravenous infusions of sodium lactate or physiological saline.
Description of sodium lactate infusion. At 4 or 5 d after stereotaxic
surgery the HR, RR, and MAP were recorded 5 min before infusions
(baseline) and for 15 min during the infusions. The lactate infusion
procedure has been described previously (Shekhar et al., 1996). Briefly,
freely moving rats in home cages were given intravenous infusions of
either 0.9% saline vehicle or 0.5 M sodium lactate in vehicle (10 ml/kg
over 15 min), similar to clinical lactate infusions (Liebowitz et al., 1986).
Cardiovascular responses that were reported are themaximumchange in
HR (in beats/min), RR (in breaths/min), and MAP (in mmHg) for each
animal.
Social interaction test.The social interaction (SI) test is a fully validated
test of experimental anxiety-like behavior in rats (File, 1980), and the
procedure as used in our laboratory has been described previously (Sand-
ers et al., 1995; Shekhar and Katner, 1995). The apparatus itself consists
of a solid wooden box with an open roof0.9 m long 0.9 mwide with
walls 0.3 m high. A video camera was fixed above the box, and all behav-
ioral tests were videotaped. A day before SI tests the “experimental” rat
and an unfamiliar “partner” rat were placed individually in the center of
the box and allowed to habituate to the environment for a 5 min period.
During the SI test the two rats were placed together in the center of the
box, and the number of seconds of nonaggressive physical contact
(grooming, sniffing, crawling over and under, etc.) initiated by the ex-
perimental rat was counted. A baseline SI test was performed72 h after
intravenous catheterization but before osmoticminipump implantation.
Another SI test was performed 6–8 d after infusions of either D-AG or
L-AG into the DMH region through osmotic minipumps and immedi-
ately after intravenous infusions of either saline or sodium lactate. Ses-
sions were scored at a later time by two raters, of whom at least one was
blind to any drug treatment.
Experimental procedures
Experiment 1. Lactate response in panic-prone and control rats for double-
labeling glutamate receptor and c-Fos in the DMH. At 5 d after stereotaxic
surgery the rats (n 24) implanted with either L-AG or D-AG pumps in
the DMH (n  12 each) were assigned randomly to lactate or saline
groups and were given their assigned intravenous infusion (saline or
sodium lactate; n 12 each); the changes inHR andMAPwere recorded
5 min before infusions (baseline) and 15 min during the infusions. After
the infusions, the animals were perfused, and their brains were removed
and processed for immunocytochemistry as described in immunocyto-
chemistry methods below.
Experiment 2. Effects of glutamate receptor antagonists in the DMH on
lactate responses in panic-prone rats. First the rats (n 6 each) with L-AG
pumps implanted in the DMHwere confirmed to be “anxious” in the SI
test and reactive to lactate infusions by postoperative day 4. On day 6 the
stylette from the vertical arm of the pump cannula of these rats was
removed, an injection cannula was inserted into the guide, and they were
given an acute 100 nl injection of one of the following drug solutions:
artificial CSF (vehicle), the selective competitive NMDA antagonist D,L-
aminophosphonopentanoic acid (D,L-AP-5; 1, 10, or 100 pmol) or its
inactive isomer L-AP-5 (100 pmol), the selective noncompetitive NMDA
antagonist dizocilpine maleate, ()-5-methyl-10,11-dihydro-5H-
dibenzo [a,d]cyclohepten-5,10-imine maleate (MK-801; 25 or 125
pmol), the selective competitive AMPA antagonist CNQX (50, 250, or
500 pmol), or the selective noncompetitive AMPA antagonist 4-(8-
methyl- 9H-1,3-dioxolo[4,5-h][2,3]benzodazepin-5-yl)-benzenamine
dihydrochloride (GYKI52466; 250 or 500 pmol) in a counterbalanced
order into the DMH and tested again with lactate infusions. On day 8 a
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similar procedure was repeated, but this time the acute injection into the
DMH was the remaining (artificial CSF or glutamate antagonists) drug.
At the end of the experiments the rats were killed, and the brains were
sectioned for histological examination of injection/infusion sites.
Immunocytochemical methods for experiment 1
Perfusion. At 90 min after the last sodium lactate infusion (i.e., in rats
with post-L-AG or D-AG pump infusions), the rats were anesthetized
with an overdose of sodium pentobarbital (40 mg/kg, i.p.) and then
perfused transcardially with 0.05 M PBS (250 ml), followed by 0.1 M
sodiumphosphate buffer (PB; 250ml) containing 4%paraformaldehyde
and 3% sucrose. Brains were removed and postfixed for 24 h in the same
fixative, rinsed for 24 h in 0.1 M PB, and then placed in cryoprotectant
(30% sucrose in 0.1 M PB) for an additional 4–5 d. To maintain a con-
sistent plane for coronal sections, we placed the brains in a rat brain
matrix (model RBM-4000C; ASI Instruments, Warren, MI) and cut
them with a razor blade at approximately 5.20 mm bregma (at the
caudal border of the mamillary bodies). Brains were frozen in cooled
liquid isopentane made by immersing a plastic vessel containing isopen-
tane into a container filled with dry ice. Serial coronal sections (30 m)
were cut with a cryostat and then were placed immediately in cryopro-
tectant consisting of 27%ethylene glycol and 16%glycerol in 0.05MPB to
yield six alternate sets of sections (three of the six alternative sets of
sections were stained for methyl green, c-Fos/NR1, and c-Fos/GluR2/3).
Sections were stored at 20°C until immunohistochemical processing.
All solutions had a pH of 7.4.
Minipump cannula placement verification. One series of coronal sec-
tions was mounted on slides, dried overnight, hydrated, stained with 1%
methyl green solution in H2O (catalog #198080; Sigma, Poole, UK),
dehydrated, andmounted with coverslips with the use of DPXmounting
medium (BDH Laboratory Supplies, Poole, UK). Minipump cannula tip
placement was verified at 400magnification via a LeicaDMEbinocular
microscope (Fisher Scientific, Leicestershire, UK) by an investigator
(P.L.J.) who was blind to the experimental treatment of the animals.
GABA immunohistochemistry. One series of hypothalamic brain sec-
tions was immunostained for GABA, which was accomplished by using
primary antibodies directed at GABA (rabbit anti-GABA polyclonal
affinity-purified antibody, catalog #2052; Sigma) (diluted 1:15,000). For
GABA immunostaining the free-floating sections were washed in 0.05 M
PBS for 30 min and then incubated in 1% H2O2 in PBS for 20 min.
Sections then were washed for 10 min in PBS and for 20 min in PBS with
0.3% Triton X-100 (PBST). Sections next were incubated for 14–16 h in
PBST with primary antibody solution at room temperature. After a 30
min wash in PBST the sections were incubated for 2 h in a biotinylated
swine anti-rabbit IgG secondary antibody (GABA, catalog #E0353;
DAKO, Cambridgeshire, UK) (diluted 1:500). Sections were washed
again for 30min in PBST and then were incubated for 1.5 h in an avidin–
biotin complex (catalog #PK-6100; Vector Laboratories, Burlingame,
CA) (diluted 1:500). Substrate for chromogen reaction was 0.01% 3,3-
diaminobenzidine tetrahydrochloride (DAB; catalog #D-5637; Sigma) in
PB containing 0.003% H2O2 and a 2% nickel sulfate solution. Substrate
reactions were run for 10 min for GABA. All sections were mounted on
clean glass slides, dried overnight, dehydrated, andmounted with cover-
slips with the use of DPX mounting medium (BDH Laboratory Sup-
plies). All washes and incubations were done in 24-well polystyrene
plates with low-frequency shaking on an orbital shaker.
Double immunohistochemistry. Two series of hypothalamic brain sec-
tionswere double immunostained sequentially for c-Fos protein first and
either NR1 or GluR2/3 afterward. Double immunostaining for c-Fos
protein and either NR1 or GluR2/3 protein was accomplished by using
primary antibodies directed against c-Fos (rabbit anti-c-Fos-polyclonal
affinity-purified antibody, catalog #PC38, Ab-5; Calbiochem, La Jolla,
CA) (diluted 1:10,000) and either NR1 (goat anti-NR1-polyclonal,
affinity-purified IgG antibodywith epitopemapping at the C terminus of
NMDA1 of human origin; catalog #sc1467; Santa Cruz Biotechnology,
Santa Cruz, CA) (diluted 1:500) or GluR2/3 (rabbit anti-GluR2 with an
epitopemapping at the C terminus peptide of theGluR2 of rat origin that
recognizes both GluR2 and GluR3, which have nearly identical
C-terminal sequences; catalog #AB1506; Chemicon, Temecula, CA) (di-
luted 1:300). Free-floating sections were washed in 0.05 M PBS for 30min
and then incubated in 1% H2O2 in PBS for 20 min. Sections next were
washed for 10min in PBS and for 20min in PBS with 0.3% Triton X-100
(PBST). Then the sections were incubated for 12–16 h in PBST with
primary antibody solution at room temperature. After a 30 min wash in
PBST the sections were incubated for 2 h in the appropriate secondary
antibody [(c-Fos, GluR2/3: biotinylated swine anti-rabbit IgG, catalog
#E0353; Dako, Carpinteria, CA) (diluted 1:500) (NR1: biotinylated rab-
bit anti-goat IgG, catalog #BA5000; Vector Laboratories) (diluted
1:500)]. Sections were washed again for 30 min in PBST and then incu-
bated for 1.5 h in an avidin–biotin complex (catalog #PK-6100; Vector
Laboratories) (diluted 1:500). Substrates for chromogen reactions were
Vector SG (c-Fos, catalog #SK-4700; Vector Laboratories) or 0.01%DAB
(NR1 and GluR2/3, catalog #D-5637; Sigma, St. Louis, MO) in PBS con-
taining 0.003%H2O2, pH7.4. Substrate reactionswere run for 20min for
c-Fos and NR1 or GluR2/3. All sections were mounted on clean glass
slides, dried overnight, dehydrated, and mounted with coverslips with
the use ofDPXmountingmedium (catalog #13512; ElectronMicroscopy
Sciences, Ft. Washington, PA). All washes and incubations were done in
24-well polystyrene plates with low-frequency shaking on an orbital
shaker.
Data processing for immunocytochemistry. Image analysis of GABA im-
munohistochemistry was done in the DMH and in the lateral hypothal-
amus (LH; at approximately 3.14 mm bregma) ipsilateral and con-
tralateral to the D-AG or L-AG infusions. Image analysis was done by
using the IMAGE J software (version 1.33) developed byWayne Rasband
from the NIH (publicly available at http://rsb.info.nih.gov/ij/) on high-
resolution photographs (25magnification) of hypothalamic brain sec-
tions immunostained for GABA. Photographs of GABA immunostain-
ing were taken by using the same exposure and were saved as eight-bit
gray scale images. A square area was selected (0.25 mm2) in the DMH
immediately lateral to the top of the third ventricle, and the mean gray
scale value was calculated from a histogram of the photograph from each
rat. The same was done for the LH, in which a square area (0.25 mm2)
was selected lateral to the fornix. Each dependent variable (gray scale
value of GABA immunocytochemistry) was analyzed by using a two-way
ANOVA, with lactate and isomer as main factors and side (ipsilateral vs
contralateral) as repeated measures.
Cell counts for c-Fos were done at 400magnification on a 0.85mm2
area/side (i.e., ipsilateral and contralateral) (see Fig. 1A) with a Leica
DME binocular microscope (Leica Microsystems, Nussloch, Germany)
by an investigator (P.L.J.) who was blind to the experimental treatment
of each animal. To count c-Fos-positive NR1 and GluR2/3-immunore-
active (GluR2/3-IR) cells and to control for area, we centered a 20
objective (200magnification) on the farthest point of the field of view
away from the third ventricle at 3.14 mm bregma. Then the objective
was changed to the 40 objective (400magnification). All c-Fos/NR1 or
c-Fos/GluR2/3-IR cells were counted from this point and scannedmedi-
ally to the third ventricle (representing a 0.85 mm2 area) (see Fig. 1A).
The area of the DMH that was counted was approximately square in
dimension, with the corners being themamillothalamic tract, the fornix,
the top of the third ventricle, and halfway down the third ventricle (im-
mediatelymedial from the fornix). This area thenwas divided into dorsal
and ventral halves. The DMH, as described, is particularly sensitive to
BMI-induced cardioexcitatory response (Samuels et al., 2004), receives
projections from circumventricular organs (CVOs) such as the organum
vasculosum lamina terminalis (OVLT) (Thompson and Swanson, 1998),
and has selective neurochemical changes that follow stress (Lowry et al.,
2003). The single c-Fos-immunoreactive (c-Fos-IR) and c-Fos/NR1 or
c-Fos/GluR2/3-IR cell counts were done in the dorsal DMH region [i.e.,
mainlymade up of the dorsal hypothalamic area (DA) but also including
part of the subincertal region (SubI)] and ventral DMH region [i.e.,
mainly made up of the dorsal part of the dorsomedial hypothalamic
nucleus (DMD) but also including part of the perifornical region (PeF)]
at3.14mmbregma. Because of the high numbers ofNR1-IR cells in the
DMH, high-resolution photomicrographs were taken at 200magnifi-
cation (representing 0.7 mm2 area/side for the DA/SubI and PeF/DMD)
and placed in a graphic illustration program (CorelDRAW Photoshop
11.633 forWindows; Viglen, Alperton,Middlesex, UK); a dot was placed
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over each NR1 or GluR2/3-IR nucleus to prevent overcounting or
undercounting.
Photography. Photomicrographs were obtained via a Leica bright-field
microscope, using N-plan 5, 10, 20, and 40 objective lenses
(model DMLB; Leica Microsystems), a SPOT digital camera (Diagnostic
Instruments, SterlingHeights,MI), and SPOT4.0.6 forWindows digital-
imaging software (Silicon Graphics, Mountain View, CA). Photographic
plates were prepared in CorelDRAW 11.633 for Windows (Eden Prairie,
MN).
Statistical analyses. Each dependent variable for in vivo analyses (i.e., SI
duration, HR, andMAP) was analyzed by using a two-way ANOVAwith
repeated measures, with lactate and isomer as main factors and time as
repeatedmeasures. Each dependent variable for cell counts (c-Fos, c-Fos/
NR1, NR1, c-Fos/GluR2/3, and GluR2/3-IR cells) was analyzed by using
a two-way ANOVA, with lactate and isomer as main factors. Levene’s
Test of Equality of Error Variance also was done to determine equal
variances in the groups. In the instance that there were equal variances in
the groups and in the presence of significant main effects, post hoc tests
were conducted by using a parametric Tukey’s test. In the instance that
there were unequal variances in the groups, post hoc tests were conducted
by using a nonparametric Kruskal–Wallis test. A two-tailed Pearson’s
ProductMomentwas used for all correlations. Statistical significancewas
accepted with p 0.05. All statistical analyses were performed by using
SPSS 13.0 (SPSS Science, Chicago, IL) and SYSTAT 5.02 for Windows
(Systat, Evanston, IL), and all graphs were generated by using SigmaPlot
2001 for Windows (SPSS Science).
Results
Experiment 1. Glutamate receptor and c-Fos double labeling
in panic-prone and control rats
Osmotic minipump probe placement
All minipump cannula placements resided in regions of the
DMH and posterior hypothalamus (PH) known to be cardioex-
citatory (Fig. 1A) (Shekhar and Keim, 1997; Samuels et al., 2004)
and were verified physiologically by injecting BMI under anes-
thesia and obtaining increases in HR (i.e., in which BMI elicited
50 beats/min in HR). Although there was some tissue damage
at the site of implantation, this damage was minimal and was
observed equally in the control and experimental groups, with
the majority of cells in the DMH/PH still intact surrounding the
infusion site and stained with methyl green (data not shown).
Anxiety-like behavior
A Levene’s test revealed equal variance among groups (F(3,18) 
6.2; p  0.613). Previous L-AG infusions into the DMH/PH re-
gion decreased the amount of time in SI test when comparedwith
prepump baseline and with D-AG controls. [There was an isomer
effect (F(1,18) 71.5; p 0.001) and a lactate times isomer inter-
action (F(1,18) 9.7; p 0.01), but no lactate effect (F(1,18) 0.6;
p 0.445) (data not shown).] Post hoc analyses revealed that the
L-AG decreased the duration of SI time independently of either
saline or sodium lactate infusions. There were no significant dif-
ferences in baseline SI time among treatment groups before ei-
ther D-AG or L-AG infusions.
Cardiovascular physiology
Intravenous infusions of sodium lactate elicited increases in
MAP (Fig. 1B) [between subjects results: there were no isomer
(F(1,14)  0.25; p  0.62) or lactate effects (F(1,14)  0.001; p 
0.97), but there was a lactate times isomer interaction (F(1,14) 
5.2; p 0.05); within subjects results: there was no isomer times
time interaction (F(1,14) 2.3; p 0.153), but there was a lactate
times time (F(1,14)  10.6; p  0.01 and a lactate times isomer
times time interaction (F(1,14) 6.9; p 0.03)] andHR (Fig. 1C)
[between subjects results: there were no isomer (F(1,15) 3.6; p
0.079) or lactate (F(1,15) 1.1; p 0.319) effects, but there was a
Figure 1. The effect of intravenous sodium lactate infusions on cardiovascular physiology in
rats made panic-prone with previous GABA inhibition in the DMH region. A, Distribution of
osmotic minipump placements in the DMH/PH from experiment 1. Shown are illustrations of
probeplacements from2.80 to3.30mmbregma, from3.60 to3.80mmbregma, and
from4.16 to4.30mm bregma. The treatment associated with each cannula placement is
representedby symbols (square or circle)with shading (white or black).B,C, Also shownare the
effects of sodium lactate infusions on the change in the MAP (B) and HR (C) before and after
infusions of either L-AG (a GABA synthesis inhibitor) or its inactive isomer D-AG in the DMH.
Values of the bars represent the mean; the error bars represent the SEM. *,† p 0.05.
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lactate times isomer interaction (F(1,15)  5.2; p  0.04); within
subjects results: there was no lactate times time interaction
(F(1,15)  2.6; p  0.128), but there was an isomer times time
interaction (F(1,15)  5.9; p  0.03) and a lactate times isomer
times time interaction (F(1,15) 7.11; p 0.02)] only in those rats
previously receiving previous L-AG infusions into the DMH/PH
region. There was also equal variance in all groups (prepump
MAP, Levene’s F(3,14)  0.58; p  0.640; postpump MAP, Lev-
ene’s F(3,14)  0.39; p  0.761; prepump HR, Levene’s F(3,14) 
0.56; p  0.649) except postpump HR (Levene’s F(3,14)  4.15;
p  0.025). As predicted, there was no physiological arousal to
the lactate infusions in the control rats that received D-AG infu-
sions into the DMH/PH region or before either L-AG or D-AG
minipump infusions (Fig. 1B,C). Post hoc analysis revealed that
sodium lactate infusions increased HR and MAP only in L-AG
rats and that the increase inMAPandHRoccurred between 6 and
8 min after intravenous infusions, respectively. The mean base-
line values for each treatment groupwere 124 4 SEM, 135 20
SEM, 123 1 SEM, and 110 5 SEMmmHg forMAP and 408
34 SEM, 415 8 SEM, 398 22 SEM, and 374 11 SEM BPM
forHR for D-AG/Sal, D-AG/Lac, L-AG/Sal, and L-AG/Lac, respec-
tively. There was also equal variance in all groups for MAP (Lev-
ene’s F(3,14) 2.5; p 0.101) andHR (Levene’s F(3,15) 0.5; p
0.655), and these values did not differ between treatment groups
when we used a two-way ANOVA [MAP: isomer (F(1,14)  1.0;
p 0.324), lactate (F(1,14) 0.01; p 0.915), isomer times lactate
(F(1,14) 0.8; p 0.380); HR: isomer (F(1,15) 1.5; p 0.228),
lactate (F(1,15)  0.2; p  0.667), isomer times lactate (F(1,15) 
0.6; p 0.446)].
GABA immunostaining in the DMH and LH
Image analysis of photographs of GABA immunostaining in the
DMH revealed that infusion of L-AG, but not D-AG, into the
DMH region decreased the intensity of GABA immunostaining
ipsilateral, but not contralateral, to the minipump cannula in the
DMH (Fig. 2A,B) [between subjects results: there was no isomer
(F(1,20) 2.5; p 0.128) or lactate effect (F(1,20) 1.4; p 0.255)
or isomer times lactate interaction (F(1,20)  0.1; p  0.738);
within subjects results: there was an isomer times side interaction
(F(1,20)  13.5; p  0.002), but no lactate times side interaction
(F(1,20)  2.1; p  0.159) or isomer times lactate times sidej
interaction (F(1,20) 2.4; p 0.134) for mean gray scale value].
There was also equal variance in all groups (ipsilateral, Levene’s
F(3,20) 0.7; p 0.540, and contralateral, Levene’s F(3,20) 1.5;
p 0.248).
Although image analysis of photographs of GABA immuno-
staining in the LH failed to reveal any treatment effect (Fig. 2A)
[between subjects results: there was no isomer (F(1,20) 1.4; p
0.252) or lactate effect (F(1,20) 0.5; p 0.475) or isomer times
lactate interaction (F(1,20)  0.2; p  0.694); within subjects re-
sults: there was no isomer times side (F(1,20)  4.3; p  0.051),
lactate times side (F(1,20) 1.4; p 0.242) or isomer times lactate
times side interaction (F(1,20)  0.9; p  0.364) for mean gray
scale value], an isomer times side effect approached significance.
There was also equal variance in all groups (ipsilateral, Levene’s
F(3,20) 1.5; p 0.242, and contralateral, Levene’s F(3,20) 1.1;
p 0.354).
Combined glutamate receptor subunit and
c-Fos immunoreactivity
Sodium lactate infusions increased the mean number of c-Fos/
NR1-IR cells in the DMH ipsilateral [There was equal variance
among groups in the DA/SubI (Levene’s F(3,20) 2.7; p 0.072),
and therewas an isomer effect (F(1,20) 5.7; p 0.03) and isomer
times lactate effect (F(1,20) 5.0; p 0.05), but no lactate effect
(F(1,20) 3.0; p 0.10); a Levene’s test revealed unequal variance
among groups in the PeF/DMD (Levene’s F(3,20) 6.6; p 0.01);
therefore, nonparametric post hoc tests were used (Fig. 3C) for
these groups.], but not contralateral. [There was equal variance
among groups in the DA/SubI (Levene’s F(3,20) 0.3; p 0.813),
and therewas an isomer effect (F(1,20) 5.7; p 0.03) and isomer
times lactate interaction (F(1,20)  5.0; p  0.05), but no lactate
effect (F(1,20)  3.0; p  0.10); there was equal variance among
groups in the PeF/DMD (Levene’s F(3,20) 2.2; p 0.108), and
there was an isomer effect (F(1,20) 6.5; p 0.02), but no lactate
effect (F(1,20) 3.0; p 0.10) or lactate times isomer interaction
(F(1,20)  3.0; p  0.10).] to isomer infusions in only those rats
receiving previous infusions of L-AG into the DMH/PH region as
compared with D-AG controls (Figs. 3A,C, 4A).
Sodium lactate infusions failed to alter the mean number of
c-Fos/GluR2/3-IR cells in the DMH ipsilateral [Within the DA/
SubI a Levene’s test revealed unequal variance among groups
(Levene’s F(3,20) 6.7; p 0.01); therefore, nonparametric post
hoc tests were used for these groups. Within the PeF/DMD there
was equal variance among groups (Levene’s F(3,19)  1.0; p 
0.408), but there was no isomer (F(1,19)  1.1; p  0.309) or
lactate effect (F(1,20)  0.2; p  0.689) or isomer times lactate
interaction (F(1,20)  0.2; p  0.689).] or contralateral [Within
the DA/SubI a Levene’s test revealed unequal variance among
groups (Levene’s F(3,20)  10.0; p  0.001); therefore, nonpara-
metric post hoc tests were used for these groups. Within the PeF/
DMD there was equal variance among groups (Levene’s F(3,18)
Figure 2. The effect that GABA synthesis inhibition (L-AG) or D-AG controls had on the inten-
sity of GABA immunostaining in the DMH and LH.A, Mean brightness of GABA immunostaining
ipsilateral and contralateral to minipump cannulas in the DMH and LH. Values of the bars
represent the mean gray scale value; error bars represent the SEM (*p  0.002). B, High-
magnification photographs of GABA-IR cells adjacent to the minipump cannula in the DMH in
D-AG/Sal-treated (left) and L-AG/Sal-treated (right) rats. Small photographic insets in B are
cropped and enlarged images taken from original left and right photographs at higher magni-
fication. Arrows in photographic insets indicateGABA-IR cells. Scale bars:B, 200m;B, bottom
left inset, 50m; B, bottom right inset, 20m.
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2.3; p 0.111), but there was no isomer (F(1,18) 0.5; p 0.466)
or lactate (F(1,18) 4.0; p 0.061) effect or isomer times lactate
interaction (F(1,18) 0.7; p 0.632).] to isomer infusions only in
those rats receiving previous infusions of L-AG into theDMH/PH
region as compared with D-AG controls (Figs. 3A,D, 4B).
The total numbers of NR1 or GluR2/3-IR cells were similar in
either the DA/SubI or PeF/DMD (ipsilateral or contralateral) of
rats infused with either isomer (Fig. 3C,D). Additional analysis
revealed that the number of c-Fos/NR1-IR cells in the PeF/DMD
(ipsilateral to minipump infusions) was correlated positively
with difference in the mean change of HR (r2 0.23; p 0.05)
(Fig. 3B), but notMAP (r2 0.01; p 0.74) or the duration of SI
(r2 0.12; p 0.11) after lactate infusions. No additional corre-
lations were observed among c-Fos/NR1, total NR1, c-Fos/
GluR2/3, or total GluR2/3-IR cells in the DMH with changes in
cardiovascular measures from baseline to post-intravenous infu-
sions. A random sample of immunoreactive cells revealed that (1)
most NR1-IR cells had an average width of 11 m and length of
24 m, whereas GluR2/3-IR cells had an average width of 11 m
and length of 20m, and (2) the vastmajority ofNR1 andGluR2/
3-IR cells had amorphology consistent with neurons (Fig. 4A,B).
Within the DMH (i.e., DA/SubI and PeF/DMD) the numbers of
NR1 andGluR2/3-IR neuronswere expressed ubiquitously.With
the exception of NR1-IR cells in the DMD, there did not appear
to be any regional difference in the size and shape of NR1 and
GluR2/3-IR cells in the DMH. Within the pars compacta region
Figure 3. Graphs indicating c-Fos responses in dorsal hypothalamic cells expressing either
the NMDA or AMPA receptor subunits (NR1 and Glu2/3 receptor subunits, respectively). A,
Illustration of the DMH region at3.14 mm bregma adapted from a standard stereotaxic rat
brain atlas indicating unilateral minipump placement and gray outlines indicating regions in
which numbers of c-Fos/NR1 or c-Fos/GluR2/3 double-IR cells were counted. B, The mean
number of c-Fos/NR1-IR cells in the PeF/DMD ipsilateral to the D-AG or L-AG infusions correlated
with changes in HR from baseline to post-intravenous infusions. C, Graphs indicate number of
c-Fos-positive NR1-IR neurons in the DMH region ipsilateral (left) and contralateral (right) to
D-AG or L-AG infusions. Barswith black lines equal the number of c-Fos/NR1-IR neurons SEM;
open bars with gray lines equal the total number of NR1-IR neurons SEM. Numbers above
open gray bars represent the approximate percentage of the total number of NR1-IR neurons
that are c-Fos positive. D, Graphs indicate the number of c-Fos-positive GluR2/3-IR neurons in
the DMH region ipsilateral (left) and contralateral (right) to D-AG or L-AG infusions. Bars with
black lines equal the number of c-Fos/GluR2/3-IR neurons SEM; open bars with gray lines
equal the total numberofGluR2/3-IRneuronsSEM.Numbers aboveopengraybars represent
the approximate percentage of the total number of GluR2/3-IR neurons that are c-Fos positive.
*p 0.05. f, Fornix; mt, mamillothalamic tract; no., number.
Figure 4. Photographs of cellular responses (i.e., the presence of c-Fos) in either NMDA or
AMPA receptor subunit-expressing cells in the DMH region. Photographs show c-Fos-IR nuclear
staining (blue) and NR1-IR (A) or GluR2/3-IR (B) cytoplasmic staining (brown) in the DA of each
treatment group, which is indicated in the bottom corner of each photograph (e.g., D-AG/Sal).
Scale bars: low-magnification photographs, 25m; small inset photographs, 12m.
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of the DMD most NR1-IR cells were smaller (i.e., 6–7 m in
diameter).
Total c-Fos immunoreactivity
Although c-Fos immunocytochemistry was done under identical
conditions before incubations with the NR1 and GluR2/3 to ver-
ify similar numbers of c-Fos-IR cells, we also counted the total
number of c-Fos-IR cells in the same areas to verify that the total
numbers of c-Fos-IR cells were not significantly different. Com-
parisons of total numbers of c-Fos from the NR1 and GluR2/3
immunocytochemical studies (using a two-way ANOVA with
lactate and isomer as main factors and the immunocytochemical
run as a repeated measure) did not reveal significant differences
in the total number of c-Fos-IR cells in any region or treatment
group (Fig. 5A,B) [within subjects results: there were no isomer
times side (F(1,20) 0.1; p 0.803), lactate times side (F(1,20)
0.7; p 0.410), or isomer times lactate times side (F(1,20) 0.2;
p  0.666) interactions]. Furthermore, the total numbers of
c-Fos in the NR1 and GluR2/3 immunocytochemical run were
highly correlated in each of the subregions of the DMH [ipsilat-
eral PeF/DMD (r2 0.80; p 0.0001), contralateral PeF/DMD
(r2  0.31; p  0.0005), ipsilateral DA/SubI (r2  0.65; p 
0.0001), and contralateral DA/SubI (r2 0.56; p 0.0001) (data
not shown)].
Experiment 2. Effects of glutamate receptor antagonists in
the DMH on lactate responses in rats with L-AG pumps
in the DMH
Osmotic minipump probe placement
Once again, all minipump cannula placements resided in regions
of the DMH and PH known to be cardioexcitatory and were
verified physiologically by injecting BMI under anesthesia and
eliciting increases in HR50 beats/min.
Effects of blocking NMDA receptors in the DMH on intravenous
lactate-induced panic-like response
The overall ANOVA revealed that, when intravenous lactate in-
fusions were given to rats with L-AG Alzet pumps in the DMH
after pretreatment with the competitive NMDA antagonist AP-5,
there were significant effects of treatment with different doses of
AP-5 (Fig. 6A) on HR (F(4,25) 49.2; p 0.001), MAP (F(4,25)
7.3; p 0.001), RR (F(4,25) 24.0; p 0.001), and SI (F(4,25)
6.8; p 0.005). There was equal variance among groups for HR
(Levene’s F(4,25) 0.4; p 0.812), MAP (Levene’s F(4,25) 1.5;
p  0.238), RR (Levene’s F(4,25)  1.7; p  0.196), and SI (Lev-
ene’s F(4,25) 2.7; p 0.053). In the group thatwas assigned to be
injectedwith its inactive isomer L-AP-5 at a dose equivalent to the
highest dose of AP-5 given (Fig. 6B), sodium lactate induced
similar behavioral and physiological responses in L-AG-treated
rats [HR (F(2,17)  32.9; p  0.0001), MAP (F(2,17)  10/0; p 
0.03), RR (F(2,17) 38.3; p 0.0001), and SI (F(2,17) 19.4; p
0.001]. There was equal variance among groups for HR (Levene’s
F(2,15) 0.6; p 0.580), MAP (Levene’s F(2,15) 1.3; p 0.296),
RR (Levene’s F(2,15) 2.0; p 0.169), and SI (Levene’s F(2,15)
1.1; p  0.366). Similarly, there were significant effects of treat-
mentwith different doses of the noncompetitiveNMDA receptor
blocker dizocilpine (MK-801) (see Fig. 8) on HR (F(3,20) 23.7;
p  0.0001), RR (F(3,20)  19.4; p  0.0001), and SI (F(3,20) 
10.2; p 0.0001), but not onMAP (F(3,20) 1.5; p 0.24). There
was equal variance among groups for HR (Levene’s F(3,20) 0.9;
p 0.470),MAP (Levene’s F(3,20) 2.0; p 0.149), RR (Levene’s
F(3,20) 1.8; p 0.172), and SI (Levene’sF(3,20) 1.3; p 0.288).
Post hoc tests in each of these groups revealed that, when these
rats were tested at baseline with intravenous lactate infusions,
therewere no significant changes inHR, BP, RR, or SIwith lactate
infusions before pump implantation (Fig. 6A–C, baseline). After
L-AG Alzet pump implantation into the DMH, when these ani-
mals were injected with artificial CSF into the DMH and were
given intravenous sodium lactate infusions on day 4, they dem-
onstrated reactivity to intravenous lactate infusions with signifi-
cant increases in HR, BP, RR, and SI (vehicle plus L-AG; Tukey’s
post hoc tests; p  0.05) (Fig. 6A–C). Preinjection of AP-5 or
MK-801 into the DMH, followed by infusion with intravenous
sodium lactate, blocked the response to lactate infusions (Fig.
6A,C) in a dose-dependent manner in all parameters (Tukey’s
post hoc test; p  0.05 between vehicle and AP-5 or MK-801
doses). Preinjection of the highest dose of the inactive isomer
L-AP-5 into the DMH, followed by infusion with intravenous
sodium lactate, failed to block the response to lactate infusions
Figure 5. Graphs indicating total numbers of c-Fos-IR cells in dorsal hypothalamic cells and
c-Fos-IR cells that expressed either the NMDA or AMPA receptor subunits (NR1 and Glu2/3
receptor subunits, respectively). Shaded bars with black lines represent the number of NR1-IR
(A) orGluR2/3-IR (B) cells that also expressed c-Fos, and bars with gray lines in A andB indicate
the total number of c-Fos-IR cells in each treatment group. These counts were subdivided into
the PeF/DMD and DA/SubI regions (see Fig. 3A) ipsilateral and contralateral to the D-AG or L-AG
infusions. *p 0.05. f, Fornix; mt, mamillothalamic tract; no., number.
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(Fig. 6B). Thus blocking NMDA receptors in the DMH clearly
blocked the lactate-induced panic-like response in these rats.
Effects of blocking AMPA receptors in the DMH on intravenous
lactate-induced panic-like response
The overall ANOVA revealed that there were significant effects of
lactate infusions in rats assigned to treatment with different doses
of the competitive AMPA receptor antagonist CNQX (Fig. 7A)
on HR (F(4,25)  19.2; p  0.0001), MAP (F(4,25)  7.0; p 
0.005), RR (F(4,25) 22.0; p 0.0001), and SI (F(4,25) 21.5; p
0.0001). There was unequal variance among groups for HR (Lev-
ene’s F(4,25) 3.3; p 0.025), MAP (Levene’s F(4,25) 5.0; p
0.004), and RR (Levene’s F(4,25)  3.6; p  0.018) but equal
variance for SI (Levene’s F(4,25) 1.2; p 0.337). Similarly, there
were significant effects of lactate infusions in rats assigned to the
noncompetitive AMPA receptor antagonist GYKI (Fig. 7B) on
HR (F(3,20) 19.5; p 0.0001),MAP (F(3,20) 3.7; p 0.05), RR
(F(3,20)  18.9; p  0.0001), and SI (F(3,20)  14.3; p  0.0001).
Figure 6. A, Changes in HR (beats/min), MAP (in mmHg), RR (breaths/min), and SI time (in
seconds) elicited by lactate infusions at baseline (before L-AG pump) and after L-AG pump plus
injectionof either vehicle (100nl) or the competitiveNMDAantagonistAP-5 (1, 10, or 100pmol)
into the DMH of rats. Significantly different from *pre-L-AG and †AP-5 (100 pmol); p 0.05.B,
Changes in HR,MAP, RR, and SI time elicited by lactate infusions at baseline (before L-AGpump)
and after L-AG pump plus injection of either vehicle (100 nl) or L-AP-5 (an inactive isomer of
AP-5; 100 pmol) into the DMH of rats. Significantly different from *pre-L-AG; p 0.05. C,
Changes in HR, MAP, RR, and SI elicited by lactate infusions at baseline (before L-AG pump) and
after L-AGpumpplus injectionof either vehicle (100nl) or thenoncompetitiveNMDAantagonist
MK-801 (25 and 125 pmol) into the DMH of rats. Significantly different from *pre-L-AG and
†MK-801 (125 pmol); p 0.05.
Figure 7. A, Changes in HR (beats/min), MAP (in mmHg), RR (breaths/min), and SI time (in
seconds) elicited by lactate infusions at baseline (before L-AG pump) and after L-AG pump plus
injection of either vehicle (100 nl) or the competitive AMPA antagonist CNQX (50, 250, or 500
pmol) into the DMH of rats. B, Changes in HR, MAP, RR, and SI elicited by lactate infusions at
baseline (before L-AG pump) and after L-AG pump plus injection of either vehicle (100 nl) or the
noncompetitive AMPA antagonist GYKI52466 (250 and 500 pmol) into the DMH of rats. *Sig-
nificantly different from pre-L-AG; p 0.05.
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There was equal variance among groups for HR (Levene’s
F(3,20) 3.1; p 0.050), MAP (Levene’s F(3,20) 3.0; p 0.056),
RR (Levene’s F(3,20) 1.0; p 0.404), and SI (Levene’s F(3,20)
1.9; p 0.165).Once again, post hoc tests showed that, when these
rats were tested at baseline with intravenous lactate infusions,
therewere no significant changes inHR, BP, RR, or SIwith lactate
infusions before pump implantation (Fig. 7A,B, baseline). After
L-AG Alzet pump implantation into the DMH, when these ani-
mals were injected with artificial CSF into the DMH and were
given intravenous sodium lactate infusions on day 4, they dem-
onstrated reactivity to intravenous lactate infusions with signifi-
cant increases in HR, BP, RR, and SI (vehicle plus L-AG; Tukey’s
post hoc tests; p  0.05) (Fig. 7A,B). Preinjection of CNQX or
GYKI into the DMH, followed by infusion with intravenous so-
dium lactate, failed to block the response to lactate infusions (Fig.
7A,B) at any of the doses tested in all parameters [Kruskal–Wallis
post hoc tests for CNQX (HR, MAP, RR) and Tukey’s post hoc
tests for GYKI and CNQX (SI); p  0.05 between vehicle and
drug doses]. Thus blocking AMPA receptors in the DMH failed
to block the lactate-induced panic responses in rats with disrup-
tion of GABA inhibition in the DMH.
Discussion
Sodium lactate infusions (intravenously) elicited robust panic-
like responses in rats with chronic inhibition of GABA synthesis
in the DMH region (i.e., panic-prone rats), once again confirm-
ing our previous reports about this animal model of panic disor-
der (Shekhar et al., 1996; Shekhar and Keim, 1997, 2000). Rats
receiving chronic infusions of L-AG into the DMH in experiment
1 had reduced GABA immunostaining restricted to the DMH, as
compared with D-AG controls, which was correlated inversely
with the duration of social interaction and is consistent with
previous studies (Abshire et al., 1988; Shekhar et al., 1996). Im-
munocytochemical labeling revealed that lactate selectively in-
creased cellular responses (i.e., c-Fos induction) in DMH neu-
rons expressing theNMDA receptor, but not theAMPA receptor,
in “panic-prone” rats. Furthermore, cellular responses inNMDA
receptor-expressing neurons in the DMH correlated with
changes in HR after sodium lactate. Only a subset of NMDA
receptor-expressing cells responded to L-AG plus lactate, im-
plicating them in panic-like responses. The other NMDA-
expressing cells could be involved in other functions attributed to
the DMH, such as feeding, temperature regulation, and circadian
rhythms (Chou et al., 2003; Gooley et al., 2006). One must use
caution when interpreting neural circuitry data based on
immediate-early gene induction (Morgan and Curran, 1989);
therefore, this anatomical finding was confirmed additionally by
pharmacological studies in which injecting the selective antago-
nists of NMDA receptors AP-5 and MK-801, but not vehicle or
the selective AMPA receptor antagonists CNQX or GYKI, into
the DMH blocked lactate-induced panic responses in a dose-
dependentmanner. This evidence clearly supports not only a role
of glutamate mechanism involved the lactate response in rats
with GABA dysfunction in the DMH but also a selective role of
NMDA receptors in the DMH in mediating the mobilization of
panic-like response in these lactate-sensitive rats. A schema de-
scribing important sources of GABA and glutamate in the DMH
and their hypothetical role is illustrated in Figure 8.
The presence of both NMDA and AMPA receptors in the
DMH is well established by a variety of techniques, including
receptor binding (Meeker et al., 1994), electrophysiology (Bailey
et al., 2003), and pharmacological studies (Soltis and DiMicco,
1991; Bailey and DiMicco, 2001; Goren et al., 2003) (see also
Introduction). However, the functional roles of the different glu-
tamate receptors in the DMH appear to be much more complex.
The presence of a tonic GABAergic inhibition appears to have a
potent modulatory role on the functions of the glutamate recep-
tors. For example, under normal conditions when the tonic
GABAergic inhibition is intact in the DMH, reducing glutamate
excitation with direct injections of glutamate receptor antago-
nists into the DMH increases exploratory behavior but has no
effect on anxiety-related behavior, as measured by the elevated
Figure 8. Summary schema of glutamatergic (Glu) and GABAergic input into the DMH/PeF
and important efferent brain regions implicated in the regulation of panic-like responses.
GABAergic and glutamatergic neurons are represented by circles attached to dashed or solid
lines, respectively. Sources of GABA include local interneurons as well as efferent brain regions
such as the lateral septum (LS) andmedial preoptic area (mPOA) (Feldblum et al., 1993; Risold
and Swanson, 1997; Thompson and Swanson, 1998; Herman et al., 2003). This GABAergic input
appears to inhibit the DMH tonically, because inhibiting the mPOA increases cellular activity in
the DMH (Satoh et al., 2004) and exaggerates cardioexcitatory responses in L-AG plus lactate-
treated rats (Shekhar and Keim, 1997); injections of L-AG into the LS also make rats prone to
having panic-like physiological responses to intravenous infusions of 0.5 M sodium lactate (S.
KeimandA. Shekhar, unpublishedobservations). Anotherwell known regulatory afferentof the
hypothalamus is themedial prefrontal cortex (mPFC) (Bard, 1928;BardandMountcastle, 1948),
which innervates the DMH (Vertes, 2004) and appears to inhibit the DMH tonically (Bard, 1928;
Bard andMountcastle, 1948;McDougall et al., 2004), presumably via glutamatergic projections
onto local GABAergic interneurons in theDMH,as is the case in theamygdala (Quirk et al., 2003).
Glutamatergic input that excites theDMH/PeF regionappears to arise fromafferent sites suchas
theCVOs [i.e., OVLTand subfornical organ (SFO) (Richard andBourque, 1992;Grobet al., 2003)],
the amygdala (Soltis et al., 1998), and also the insular cortex (IC) (Cechetto and Chen, 1990;
Butcher and Cechetto, 1998). Furthermore, systemic injections of yohimbine, which provokes
panic attacks inmanypanic disorder patients,may inducepanic-like responses via brain regions
such as the DMH, because exposure to stress (Lowry et al., 2003) and fearful stimuli (Shekhar et
al., 1994) increases norepinephrine (NE) concentrations in the DMH, and injecting1-blockers
into theDMHof panic-prone rats before yohimbine infusions blocks panic-like responses (Shek-
har, unpublished observations). Afferent targets of the DMH that are implicated in the regula-
tion of panic-like responses are listed also (Chamberlin and Saper, 1994; Thompson and Swan-
son, 1998; Fontes et al., 2001; Chen et al., 2004). BNST, Bed nucleus of the stria terminalis; IML,
intermediolateral cell column of spinal cord; LC, locus ceruleus; nTS, nucleus of solitary tract;
PBN, parabrachial nucleus; PVN, paraventricular hypothalamic nucleus; RVLM, rostroventrolat-
eral medulla.
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plus-maze test or the Vogel conflict test (Jardim and Guimaraes,
2004). The anxiogenic response noted with chronic disruption of
GABA synthesis and hence reduced GABAergic inhibition in the
DMH is blocked by reducing glutamate releasewith a presynaptic
metabotropic receptor agonist (Shekhar and Keim, 2000). The
results of the present report demonstrate that the behavioral activa-
tion and anxiogenic effects unmasked by chronically reducing the
tonic GABAergic inhibition in the DMH primarily are mediated
postsynaptically by the NMDA type glutamate receptors.
In addition to blocking the anxiogenic responses, injections of
NMDA antagonists also completely blocked the lactate-induced
cardio-respiratory physiological responses, whereas AMPA an-
tagonists had no effects. This is in contrast to the physiological
responses elicited by acute GABA blockade in the DMH, where
both NMDA and AMPA receptor antagonists are partially effec-
tive in blocking the physiological responses (Soltis and DiMicco,
1991), and injection of NMDA and AMPA receptor agonists into
the DMH elicits panic-like physiological and behavioral re-
sponses (Soltis and DiMicco, 1992). It appears that chronic re-
duction of GABA inhibition results in long-term adaptation of
the glutamate neurotransmission in this region, resulting in a
dominance of the NMDA-mediated excitatory neurotransmis-
sion. Such a change could be attributable either to plasticity re-
sulting in an enhanced role of NMDA receptors or to a desensi-
tization of the non-NMDA receptor function in the DMH. Such
plastic changes in both types of ionotropic glutamate receptors
have been reported in the hypothalamus. For example, NR1 sub-
unit expression is increased in the hypothalamus of rats that are
prone to sympathoexcitatory responses after the left coronary
artery has been ligated to induce heart failure (Li et al., 2003).
Similarly, chronic stress and early life adverse events have been
shown to increase hypothalamic NMDA receptor subunit ex-
pression (Lee et al., 2003). The changes in composition of the
NMDA receptor subunits and the receptor efficacy in the hypo-
thalamus also have been reported for a number of other stimuli,
such as light and dark cycle (Pennartz et al., 2001), aging (Gore et
al., 2002; Miller and Gore, 2002), drug abuse (Zhu et al., 1999),
and chronic stress (Ziegler et al., 2005). The changes also could
occur in AMPA receptors such that chronic disruption of GABA
inhibition could result in desensitization of these non-NMDA
receptors. For example, such a mechanism has been reported in
the hypothalamic magnocellular neurons regulating oxytocin
and vasopressin secretion (Sladek et al., 1998).
Another possibility is that different stimulimay activate only a
subset of glutamate receptors in the hypothalamus to elicit the
physiological responses in the animal. For example, previous
studies have demonstrated that hemorrhagic stimuli activate the
hypothalamic vasopressin secretion selectively via the NMDA,
and not non-NMDA, glutamate receptors (Yamaguchi and Wa-
tanabe, 2002). Similarly, NMDA receptors are implicated in the
vasopressin, but not the cardiovascular, responses to hyperos-
motic stimuli in the median preoptic regions (Yamaguchi and
Watanabe, 2002). Thus lactate challenges in rats with chronic
reduction in GABA inhibition in the DMH preferentially could
be activating a glutamatergic system that selectively involves the
NMDA postsynaptic receptors and not the AMPA receptors.
The data presented here support the working hypothesis that
GABAergic dysfunction in the hypothalamus of humans poten-
tially could lead to panic disorder and sensitivity to panic-like
responses elicited by chemical challenges such as sodium lactate
(Shekhar et al., 2002). Supporting such a hypothesis, panic dis-
order patients have demonstrated deficits in central GABA con-
centrations (Goddard et al., 2001) and benzodiazepines, which
positively modulate the GABAA receptor, attenuate sodium
lactate-induced panic-related responses in panic patients (Pohl et
al., 1994), and attenuate panic-like responses evoked from either
chemical stimulation of the DMH region (Shekhar, 1994) or by
intravenous sodium lactate infusions in rats with GABA dysfunc-
tion in theDMHregion (Shekhar andKeim, 2000). In addition to
the DMH, dysfunctional GABA–glutamate tone in the dorsal
periaqueductal gray (Jenck et al., 1995) (for review, see Charney
and Deutch, 1996) or amygdala (Sajdyk and Shekhar, 2000) (for
review, see Shekhar et al., 2003) also has been implicated in the
etiology of panic-like conditions. Overall, dysfunctional GABA–
glutamate tone in these brain regions may contribute to panic-
prone states.
Within the CNS, GABA counterbalances the actions of gluta-
mate to prevent hyperexcitation of neurons (for review, see Ly-
diard, 2003) and suggests that glutamate-mediated hyperexcita-
tion may exist in brain regions as the DMH of panic-prone rats
and panic disorder patients. In light of this, there is increasing
recognition that glutamatergic mechanisms may be a potential
avenue to develop new treatment for anxiety problems such as
panic disorder (for review, see Gorman, 2003; Millan, 2003).
Some studies have demonstrated that the noncompetitive
NMDA antagonist MK-801 (Xie and Commissaris, 1992; Xie et
al., 1995), the competitiveNMDAantagonist AP-7 (Plaznik et al.,
1994), or metabotropic glutamate receptor agonists that reduce
glutamate neurotransmission (Helton et al., 1998; Klodzinska et
al., 1999; Kellner et al., 2005) reduce anxiety-like and panic-
associated behavior in rats. These results and the present results sug-
gest that selective glutamatergic receptor agents may be potential
therapeutic strategies in treating panic disorder in humans.
In summary, rats with chronic inhibition of GABA synthesis
in the DMH develop panic-like responses after intravenous so-
dium lactate infusions, a phenomenon similar to patients with
panic disorder, as previously reported. Here we demonstrated
that lactate-induced responses increased c-Fos immunoreactivity
in DMH neurons expressing the NMDA receptor 1 (NR1) sub-
unit, but not those positive for the GluR2 and 3 subunits of the
AMPA receptors. We additionally confirmed this pharmacolog-
ically, in which injections of NMDA, but not non-NMDA, antag-
onists into the DMH resulted in dose-dependent blockade of the
HR, MAP, RR, and SI responses after lactate infusions. These
results indicate that NMDA, and not non-NMDA, type gluta-
mate receptors regulate lactate-induced panic-like responses in
rats with GABA dysfunction in the DMH.
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